CTNI-54. A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA
Lucy Gately(Walter and Eliza Hall Institute of Medical Research), Carmen Balañá(Institut Català d'Oncologia), Mark Rosenthal(The Royal Melbourne Hospital), Craig Underhill(AstraZeneca (United Kingdom)), Pedro Pérez‐Segura(Hospital Clínico San Carlos), Rosemary Harrup(University of Tasmania), Sanjeev Gill(The Alfred Hospital), Ian Collins(St. James's Hospital), Carlos Mesía(Institut Català d'Oncologia), Maria Martinez‐García(Hospital Del Mar), Elizabeth Ahern(Monash Health), Peter Gibbs(The University of Melbourne), Anthony Dowling(Monash University), Ramón De La Peñas(Fundación Hospital Provincial de Castellón), Sergio Peralta(Hospital Universitari Sant Joan de Reus), A. Long(Providence Portland Medical Center), Katharine Cuff(Eastern Health), Regina Gironés(Hospital Universitari i Politècnic La Fe), M Navarro(Instituto Ramón y Cajal de Investigación Sanitaria), Wei Hong(Walter and Eliza Hall Institute of Medical Research), Juan Manuel Sepúlveda-Sánchez(Hospital Universitario 12 De Octubre), C Olier(Hospital Universitario Fundación Alcorcón), Robert M. Campbell(Children's Health Queensland Hospital and Health Service), Óscar Gallego(Hospital de Sant Pau), Sonia Del Barco(Institut Català d'Oncologia), Stephen Brown(Ballarat Health Services), María Ángeles Vaz Salgado(Instituto Cajal), Ana Herrero(Hospital Universitario Miguel Servet), Mark Wong, J. Fuster(Hospital Universitario Son Espases), Javier Torres(Goulburn Valley Health), Zarnie Lwin(The University of Queensland), Marta Covela(Hospital Universitario Lucus Augusti), Estela Pineda(Hospital Clínic de Barcelona), Adam Cooper(Liverpool Hospital), Miriam Alonso(Hospital Universitario Virgen del Rocío), Ross Jennens
Cited by 0
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
|Science Translational Medicine|2016|1.5k